ACA
CCXI

Avoro Capital Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Avoro Capital Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-323,607
Closed -$2.44M – 40
2015
Q1 		$2.44M Buy
+323,607
New +$2.53M 0.94% 23

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Avoro Capital Advisors's CCXI Position: Q2 2015 in Review

Avoro Capital Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q2 2015, closing a stake of 323,607 shares — an estimated $2.44M sold.

Avoro Capital Advisors first reported a position in CCXI in Q1 2015 and held it in 1 quarter. The position peaked at $2.44M in Q1 2015. 70 funds tracked by Wall St. Rank hold CCXI as of Q2 2015.

  • Avoro Capital Advisors reported no remaining ChemoCentryx, Inc. position as of Q2 2015 after selling out during the quarter.
  • Avoro Capital Advisors sold 323,607 ChemoCentryx, Inc. shares in Q2 2015, an estimated $2.44M.
  • Avoro Capital Advisors first reported a position in ChemoCentryx, Inc. in Q1 2015 and held it in 1 quarter.
  • Avoro Capital Advisors's ChemoCentryx, Inc. position peaked at $2.44M in Q1 2015.
  • 70 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2015.

Based on Avoro Capital Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.